Sandbox vidit

Revision as of 19:05, 10 March 2014 by Vidit Bhargava (talk | contribs)
Jump to navigation Jump to search
 
 
 
 
 
 
Atrial flutter
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unstable
 
 
 
 
 
Stable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Look for the presence of any of these:
❑ Chronic heart failure
❑ Hypotension
❑ Acute myocardial infarction
 
 
 
 
 
❑ Administer anticoagulation therapy based on the risk of stroke, if total duration of flutter > 48 hours
❑ Administer rate control therapy (AV nodal blockers)

THEN

❑ Attempt conversion
❑ DC cardioversion
❑ Atrial pacing
❑ Pharmacological cardioversion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Assess need for therapy to prevent recurrence
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Administer antiarrythmic therapy to prevent recurrences
❑ Consider catheter ablation if antiarrhythmic therapy fails
 
 
 
 
 
 
 
 
 
 

Anticoagulation Therapy

Shown below are tables depicting the assessment of risk of stroke and the appropriate anticoagulation therapy among patients with Atrial flutter.[1]

Anticoagulation Therapy
No risk factors Aspirin 81-325 mg daily
1 Moderate risk factor Aspirin 81-325 mg daily
OR
Warfarin (INR 2.0 to 3.0, target 2.5)
Any high risk factor or
more than 1 moderate risk factor
Warfarin (INR 2.0 to 3.0, target 2.5)


Low Risk Factors Moderate Risk Factors High Risk Factors
Female gender
Age 65-74 years
Coronary artery disease
Thyrotoxicosis
Age ≥ 75 years
Hypertension
Heart failure
LV ejection fraction ≤ 35%
Diabetes mellitus
Previous stroke, TIA or embolism
Mitral stenosis
Prosthetic heart valve

Acute management of atrial flutter

Acute management of atrial flutter
Proposed therapy Recommendation
stable flutter
Conversion Atrial or transesophageal pacing
or
DC cardioversion
or
Ibutilide
or
Flecainide
or
Propafenone
or
Sotalol
or
Procainamide
or
Amiodarone
Rate control Beta blockers
or
Verapamil or diltiazem
or
Digitalis
or
Amiodarone


Acute management of atrial flutter
Proposed therapy Recommendation
Unstable atrial flutter
Conversion DC cardioversion
Rate control Beta blockers
or
Verapamil or diltiazem
or
Digitalis
or
Amiodarone

Long term management of atrial flutter

Long term management of atrial flutter
Proposed therapy Recommendation
First episode and well-tolerated atrial flutter Cardioversion alone
or
Catheter ablation
Recurrent and well-tolerated atrial flutter Catheter ablation
or
Dofetilide
or
Amiodarone
or
Sotalol
or
Flecainide
or
Quinidine
or
Propafenone
or
Procainamide
or
Disopyramide
Poorly tolerated atrial flutter Catheter ablation
Atrial flutter appearing after use of class Ic agents or amiodarone for treatment of AF Catheter ablation
or
Stop current drug and use another
Symptomatic non–CTI-dependent flutter after failed antiarrhythmic drug therapy Catheter ablation
  1. Fuster, V.; Rydén, LE.; Cannom, DS.; Crijns, HJ.; Curtis, AB.; Ellenbogen, KA.; Halperin, JL.; Kay, GN.; Le Huezey, JY. (2011). "2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines". Circulation. 123 (10): e269–367. doi:10.1161/CIR.0b013e318214876d. PMID 21382897. Unknown parameter |month= ignored (help)